Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Delta 9 Cannabis in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.33.
Current Consensus is
The current consensus among 0 investment analysts is to n/a stock in Delta 9 Cannabis. This rating has held steady since April 2021, when it changed from a Buy consensus rating.
Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the production, distribution, and sale of medical and recreational cannabis and related merchandise and devices. As of February 5, 2021, it owned and operated ten retail stores under the Delta 9 Cannabis Store brand. Delta 9 Cannabis Inc. was founded in 2012 and is headquartered in Winnipeg, Canada.